TRIM3 inhibits P53 signaling in breast cancer cells

被引:0
作者
Xinxing Wang
Yujie Zhang
Xinhong Pei
Guangcheng Guo
Bingjian Xue
Xin Duan
Dongwei Dou
机构
[1] The First Affiliated Hospital of Zhengzhou University,Department of Breast Surgery
来源
Cancer Cell International | / 20卷
关键词
TRIM3; P53; Breast cancer; Ubiquitin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 64 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Onitilo AA(2009)Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival Clin Med Res 7 4-13
[3]  
Engel JM(2014)Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study J ClinOncol 32 2142-2150
[4]  
Greenlee RT(2004)Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer J Natl Cancer Inst 96 926-935
[5]  
Mukesh BN(1979)T antigen is bound to a host protein in SV40-transformed cells Nature 278 261-263
[6]  
Vaz-Luis I(2019)Crosstalk between P53 and DNA damage response in ageing DNA Repair 80 8-15
[7]  
Shou J(2013)p53 and translation attenuation regulate distinct cell cycle checkpoints during endoplasmic reticulum (ER) stress J BiolChem 288 7606-7617
[8]  
Lane DP(2013)Structure and stability insights into tumour suppressor p53 evolutionary related proteins PLoS ONE 8 e76014-668
[9]  
Crawford LV(2019)p53 signaling in cancers Cancers 11 332-102
[10]  
Mohammadzadeh A(2008)Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells Br J Pharmacol 153 657-864